SATB2 and bladder adenocarcinoma: Beyond CK7/CK20, several studies support SATB2 and cadherin-17 (CDH17) as highly sensitive and specific colorectal markers, including in poorly differentiated tumors; their combined use improves accuracy over older two-marker panels and helps avoid misclassification of primary bladder adenocarcinoma [37,38].